Design and Synthesis of Pyrrolo[3,2-<i>d</i>]pyrimidine Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors: Exploration of Novel Back-Pocket Binders
Youichi Kawakita(Takeda (Japan)), Tomoyasu Ishikawa(Takeda (Japan)), Noriyuki Habuka, Tadashi Yusa(Takeda (Japan)), Satoshi Sogabe(Takeda (Japan)), Hiroshi Banno(Fujisawa City Hospital), Hidehisa Iwata(Takeda (Japan)), Toshiya Tamura(Takeda (Japan)), Akiko Nakayama(Max Planck Institute for Heart and Lung Research), Hidenori Kamiguchi(Takeda (Japan)), Hiroshi Miki(Takeda (Japan)), Toshimasa Tanaka(Takeda (Japan)), Yoshikazu Ohta(University of Miyazaki), Tomohiro Ohashi(Takeda (Japan))
Cited by 44
Related Papers
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Spatial regulation of VEGF receptor endocytosis in angiogenesis
|Nature Cell Biology|2013|272
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
|Journal of Medicinal Chemistry|2011|223
Structure-Based Approach for the Discovery of Pyrrolo[3,2-<i>d</i>]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors
|ACS Medicinal Chemistry Letters|2012|171
Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory Effect
|Journal of Medicinal Chemistry|1996|151